SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
37 hedge funds and large institutions have $90.1M invested in scPharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 14 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
37
Holders Change
+4
Holders Change %
+12.12%
% of All Funds
0.59%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
8
Reduced
14
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
JGC
J. Goldman & Co
New York
|
-$1.72M |
2 |
![]()
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$411K |
3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$189K |
4 |
Millennium Management
New York
|
-$48.8K |
5 |
Renaissance Technologies
New York
|
-$16.5K |